Thilo Jakob

2.2k total citations
26 papers, 582 citations indexed

About

Thilo Jakob is a scholar working on Dermatology, Immunology and Allergy and Immunology. According to data from OpenAlex, Thilo Jakob has authored 26 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Dermatology, 11 papers in Immunology and Allergy and 5 papers in Immunology. Recurrent topics in Thilo Jakob's work include Contact Dermatitis and Allergies (11 papers), Food Allergy and Anaphylaxis Research (8 papers) and Dermatology and Skin Diseases (7 papers). Thilo Jakob is often cited by papers focused on Contact Dermatitis and Allergies (11 papers), Food Allergy and Anaphylaxis Research (8 papers) and Dermatology and Skin Diseases (7 papers). Thilo Jakob collaborates with scholars based in Germany, Denmark and Sweden. Thilo Jakob's co-authors include Edzard Spillner, Johannes Ring, Sabine Müller, Simon Blank, Marcel Frick, Johannes Huss‐Marp, Jonas Lidholm, Frank I. Bantleon, Julian Köhler and Stephan Weidinger and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Journal of the American Academy of Dermatology and Allergy.

In The Last Decade

Thilo Jakob

23 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thilo Jakob Germany 11 323 204 116 99 74 26 582
Fiorella Ruchti Switzerland 11 109 0.3× 207 1.0× 160 1.4× 150 1.5× 23 0.3× 14 669
Maria P. de Leon Australia 12 498 1.5× 252 1.2× 57 0.5× 169 1.7× 22 0.3× 19 663
Françoise Bienvenu France 11 124 0.4× 68 0.3× 30 0.3× 32 0.3× 68 0.9× 22 401
R. Castillo Spain 10 258 0.8× 144 0.7× 14 0.1× 66 0.7× 25 0.3× 15 349
Krisztina Szalai Austria 15 457 1.4× 132 0.6× 86 0.7× 231 2.3× 19 0.3× 24 667
Mami Tajima Japan 12 147 0.5× 443 2.2× 33 0.3× 35 0.4× 64 0.9× 19 846
Adrie G. van Ieperen-van Dijk Netherlands 11 360 1.1× 223 1.1× 66 0.6× 128 1.3× 9 0.1× 16 513
Raquel Leão Orfali Brazil 15 321 1.0× 491 2.4× 169 1.5× 117 1.2× 8 0.1× 44 691
María Alvarado Spain 13 179 0.6× 100 0.5× 22 0.2× 82 0.8× 46 0.6× 27 416
Bárbara Cases Spain 12 381 1.2× 180 0.9× 78 0.7× 122 1.2× 15 0.2× 19 509

Countries citing papers authored by Thilo Jakob

Since Specialization
Citations

This map shows the geographic impact of Thilo Jakob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thilo Jakob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thilo Jakob more than expected).

Fields of papers citing papers by Thilo Jakob

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thilo Jakob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thilo Jakob. The network helps show where Thilo Jakob may publish in the future.

Co-authorship network of co-authors of Thilo Jakob

This figure shows the co-authorship network connecting the top 25 collaborators of Thilo Jakob. A scholar is included among the top collaborators of Thilo Jakob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thilo Jakob. Thilo Jakob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dorn, Brian R., et al.. (2024). A Fully Human Monoclonal Antibody Isolated From a Beekeeper Targets the Immunodominant IgE Epitope of Api m 10. Journal of Investigational Allergology and Clinical Immunology. 35(1). 55–57.
2.
Lapp, Thabo, et al.. (2024). Atopic Keratoconjunctivitis: Pathophysiology, Clinic, and Potential New Therapeutic Concepts. Klinische Monatsblätter für Augenheilkunde. 241(5). 607–618. 1 indexed citations
4.
Wurpts, Gerda, Werner Aberer, Heinrich Dickel, et al.. (2019). S2k-Leitlinie: Diagnostik bei Verdacht auf eine Betalaktamantibiotika-Überempfindlichkeit. Allergo Journal. 28(5). 19–51. 3 indexed citations
5.
Frick, Marcel, Jörg Fischer, Arthur Helbling, et al.. (2016). Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy. Journal of Allergy and Clinical Immunology. 138(6). 1663–1671.e9. 73 indexed citations
6.
Jensen, Rasmus K., et al.. (2015). Structure of the omalizumab Fab. Acta Crystallographica Section F Structural Biology Communications. 71(4). 419–426. 17 indexed citations
7.
Kleine‐Tebbe, Jörg & Thilo Jakob. (2015). Molekulare Allergiediagnostik. 5 indexed citations
8.
Müller, Sabine, David Rafei‐Shamsabadi, & Thilo Jakob. (2014). Problemfälle der In-vitro-Diagnostik bei Hymenopterengiftallergie. Der Hautarzt. 65(9). 780–790. 6 indexed citations
9.
Köhler, Julian, Simon Blank, Sabine Müller, et al.. (2014). Component resolution reveals additional major allergens in patients with honeybee venom allergy. Journal of Allergy and Clinical Immunology. 133(5). 1383–1389.e6. 127 indexed citations
10.
Vaerenbergh, Matthias Van, Lina De Smet, David Rafei‐Shamsabadi, et al.. (2014). IgE recognition of chimeric isoforms of the honeybee (Apis mellifera) venom allergen Api m 10 evaluated by protein array technology. Molecular Immunology. 63(2). 449–455. 15 indexed citations
11.
Weiss, Johannes M., et al.. (2009). Allergenic potential of Arnica‐containing formulations in Arnica‐allergic patients. Contact Dermatitis. 61(5). 304–306. 6 indexed citations
12.
Bruckner‐Tuderman, Leena, et al.. (2009). Contact dermatitis due to use of Octenisept® in wound care. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 7(9). 759–765. 23 indexed citations
13.
Eyerich, Kilian, Claudia Traidl‐Hoffmann, Stephanie Rombold, et al.. (2008). Lipomatous Metaplasia after Severe and Chronic Cutaneous Inflammation. Dermatology. 217(1). 52–55. 10 indexed citations
14.
Ploch, M., et al.. (2008). Skin Tolerance of a New Bath Oil Containing St. John’s Wort Extract. Skin Pharmacology and Physiology. 21(6). 306–311. 13 indexed citations
15.
Engel, Katharina, et al.. (2007). Anti‐inflammatory effect of pimecrolimus in the sodium lauryl sulphate test. Journal of the European Academy of Dermatology and Venereology. 22(4). 447–450. 21 indexed citations
16.
Hein, R., et al.. (2007). Erythema-anulare-centrifugum-artige Psoriasis cum pustulatione. Der Hautarzt. 58(9). 769–773. 4 indexed citations
17.
Weidinger, Stephan, Norman Klopp, Stefan Wagenpfeil, et al.. (2005). Association of NOD1 polymorphisms with atopic eczema and related phenotypes. Journal of Allergy and Clinical Immunology. 116(1). 177–184. 144 indexed citations
18.
Gutermuth, Jan, Heidrun Behrendt, Johannes Ring, & Thilo Jakob. (2005). Models of contact dermatitis and atopic eczema. Drug Discovery Today Disease Models. 2(2). 135–140. 2 indexed citations
19.
Jakob, Thilo, et al.. (1996). Dyshidrotic cutaneous T-cell lymphoma. Journal of the American Academy of Dermatology. 34(2). 295–297. 10 indexed citations
20.
Jakob, Thilo, K. Hermann, & Johannes Ring. (1991). Eosinophil cationic protein in atopic eczema. Archives of Dermatological Research. 283(1). 5–6. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026